About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Philadelphia | 153 Studies

Clinical Trials SchizophreniaPhiladelphia

Schizophrenia Clinical Trials in Philadelphia

Find 153 clinical trials for schizophrenia near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 153 trials

CompletedA Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia PatientsThis is a study in chronic stable Schizophrenia with the purpose to answer the question of whether agonism of the nicotinic alpha7 receptor is capable of enhancing cognition in a…NCT01730768·Garden Grove, California and 12 others CompletedDecision-making and Decision Support Among Emerging Adults With First Episode PsychosisThe purpose of this study is to evaluate the impact of an antipsychotic medication decision aid and interpersonal and cognitive factors, such as attachment style and motivation…NCT04373590·Philadelphia, Pennsylvania CompletedLong Term Study of RBP 7000 in the Treatment of Subjects With SchizophreniaThis is a Phase 3, open label study administering RBP-7000 in the treatment of patients with schizophrenia.NCT02203838·Little Rock, Arkansas and 47 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaThe objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.NCT00654706·Garden Grove, California and 25 others

CompletedAripiprazole in Adolescents With SchizophreniaThe purpose of this trial is to test the safety and efficacy of aripiprazole in adolescent patients with schizophrenia for a period of at least 6 weeks.NCT00102063·Birmingham, Alabama and 54 others

CompletedA Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With SchizophreniaThis study determined if a single dose of LY2140023 (pomaglumetad methionil) affects the electrical activity in the heart in participants with schizophrenia.NCT01606436·Garden Grove, California and 7 others

CompletedComparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderThe study will compare the effectiveness of antipsychotic medications for patients with schizophrenia or schizoaffective disorder for whom a medication change may be indicated…NCT00423878·Colton, California and 27 others

CompletedEfficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute SchizophreniaThe purpose of this study is to determine the safety and efficacy of iloperidone compared to placebo and an active comparator in the treatment of patients with schizophrenia in…NCT00254202·Little Rock, Arkansas and 41 others

CompletedCATIE-Alzheimer's Disease TrialThe CATIE Alzheimer's Disease Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project.NCT00015548·Tuscaloosa, Alabama and 33 others

TerminatedCompare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsThe primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.NCT00396214·Anaheim, California and 150 others

TerminatedStudy Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointThe purpose of this study is to determine the effect of bifeprunox or risperidone on the body weight of patients with schizophrenia.NCT00366704·Little Rock, Arkansas and 65 others

CompletedA Study of ALKS 9072 in Subjects With Chronic Stable SchizophreniaThis study will determine the pharmacokinetics (PK), safety, and tolerability of ALKS 9072 (also known as ALKS 9070) after 4 monthly doses in adults with chronic stable…NCT01493726·Atlanta, Georgia and 5 others

CompletedA Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)This randomized, multi-center, double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4917838 (bitopertin) in patients with…NCT01235585·Carson, California and 119 others

CompletedStudy Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.This study will compare bifeprunox to a currently marketed medication, Zyprexa (olanzapine), with respect to the affect on weight during the treatment of outpatients with…NCT00380224·Little Rock, Arkansas and 66 others

RecruitingA Study of Brenipatide in Adult Participants With SchizophreniaThe purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of…NCT07410507·Little Rock, Arkansas and 100 others

CompletedRP5063 in Subjects With Schizophrenia or Schizoaffective DisorderThe objective of this study is to evaluate the efficacy and safety of RP5063 relative to placebo for the treatment of schizophrenia or schizoaffective disorder.NCT01490086·Philadelphia, Pennsylvania and 14 others

CompletedEvaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.The purpose of this study is to measure the effectiveness and assess the safety of different dosages (from 3 mg/day to 12 mg/day) of the antipsychotic paliperidone…NCT00412373·Cerritos, California and 43 others

CompletedAripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.A Multicenter, Double-blind 16 Week Study on the augmentation of atypical antipsychotic with Aripiprazole in patients with Schizophrenia with inadequate response to antipsychotic…NCT00325689·Little Rock, Arkansas and 47 others

WithdrawnEffectiveness and Mechanisms of Recovery Oriented Cognitive TherapyThis study is evaluating the effectiveness of recovery oriented cognitive therapy (CT-R) for patients with schizophrenia/schizoaffective disorder.NCT05140135·Philadelphia, Pennsylvania

CompletedA Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)This multi-center, randomized, double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4917838 in participants with persistent…NCT01192867·Little Rock, Arkansas and 121 others

PreviousPage 4 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia